Safety of Roxadustat Versus Erythropoiesis-Stimulating Agents in Patients with Anemia of Non-dialysis-Dependent or Incident-to-Dialysis Chronic Kidney Disease: Pooled Analysis of Four Phase 3 Studies

INTRODUCTION: This study was conducted to elucidate the safety of roxadustat, an oral medication, in patients with non-dialysis-dependent (NDD) or incident dialysis dialysis-dependent (ID-DD) chronic kidney disease (CKD). METHODS: Safety results from four phase 3, randomized, open-label studies comp...

Descripción completa

Detalles Bibliográficos
Autores principales: Barratt, Jonathan, Dellanna, Frank, Portoles, Jose, Choukroun, Gabriel, De Nicola, Luca, Young, James, Dimković, Nada, Reusch, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10070224/
https://www.ncbi.nlm.nih.gov/pubmed/36749544
http://dx.doi.org/10.1007/s12325-023-02433-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10070224/
https://www.ncbi.nlm.nih.gov/pubmed/36749544
http://dx.doi.org/10.1007/s12325-023-02433-0

Ejemplares similares